These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 16497299)

  • 21. The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade.
    Kathawala RJ; Gupta P; Ashby CR; Chen ZS
    Drug Resist Updat; 2015 Jan; 18():1-17. PubMed ID: 25554624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The emergence of drug transporter-mediated multidrug resistance to cancer chemotherapy.
    Wu CP; Hsieh CH; Wu YS
    Mol Pharm; 2011 Dec; 8(6):1996-2011. PubMed ID: 21770407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current Understanding of Interactions between Nanoparticles and ABC Transporters in Cancer Cells.
    Yin J; Deng X; Zhang J; Lin J
    Curr Med Chem; 2018; 25(42):5930-5944. PubMed ID: 29542407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [ABC transporter proteins in multidrug resistance of microorganisms].
    Balková K; Gbelská Y
    Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):129-39. PubMed ID: 17900061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunosuppressors as multidrug resistance reversal agents.
    Morjani H; Madoulet C
    Methods Mol Biol; 2010; 596():433-46. PubMed ID: 19949935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversal of ATP-binding cassette drug transporter activity to modulate chemoresistance: why has it failed to provide clinical benefit?
    Yu M; Ocana A; Tannock IF
    Cancer Metastasis Rev; 2013 Jun; 32(1-2):211-27. PubMed ID: 23093326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ATP-binding cassette (ABC) transporters in cancer: A review of recent updates.
    Wang JQ; Wu ZX; Yang Y; Teng QX; Li YD; Lei ZN; Jani KA; Kaushal N; Chen ZS
    J Evid Based Med; 2021 Sep; 14(3):232-256. PubMed ID: 34388310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting multidrug resistance in cancer.
    Szakács G; Paterson JK; Ludwig JA; Booth-Genthe C; Gottesman MM
    Nat Rev Drug Discov; 2006 Mar; 5(3):219-34. PubMed ID: 16518375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of drug resistance in cancer chemotherapy: coordinated role and regulation of efflux transporters and metabolizing enzymes.
    Vadlapatla RK; Vadlapudi AD; Pal D; Mitra AK
    Curr Pharm Des; 2013; 19(40):7126-40. PubMed ID: 23829373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triterpenoids as reversal agents for anticancer drug resistance treatment.
    Yan XJ; Gong LH; Zheng FY; Cheng KJ; Chen ZS; Shi Z
    Drug Discov Today; 2014 Apr; 19(4):482-8. PubMed ID: 23954181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.
    Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS
    Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repurposing Tyrosine Kinase Inhibitors to Overcome Multidrug Resistance in Cancer: A Focus on Transporters and Lysosomal Sequestration.
    Krchniakova M; Skoda J; Neradil J; Chlapek P; Veselska R
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32365759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microparticles and their emerging role in cancer multidrug resistance.
    Gong J; Jaiswal R; Mathys JM; Combes V; Grau GE; Bebawy M
    Cancer Treat Rev; 2012 May; 38(3):226-34. PubMed ID: 21757296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ellagic Acid and Schisandrins: Natural Biaryl Polyphenols with Therapeutic Potential to Overcome Multidrug Resistance in Cancer.
    Yoganathan S; Alagaratnam A; Acharekar N; Kong J
    Cells; 2021 Feb; 10(2):. PubMed ID: 33669953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of multidrug resistance in cancer.
    Gillet JP; Gottesman MM
    Methods Mol Biol; 2010; 596():47-76. PubMed ID: 19949920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapy-induced resistance by ATP-binding cassette transporter genes.
    Gillet JP; Efferth T; Remacle J
    Biochim Biophys Acta; 2007 Jun; 1775(2):237-62. PubMed ID: 17572300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multidrug resistance in cancer: its mechanism and its modulation.
    Pauwels EK; Erba P; Mariani G; Gomes CM
    Drug News Perspect; 2007; 20(6):371-7. PubMed ID: 17925891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategies for overcoming ABC-transporters-mediated multidrug resistance (MDR) of tumor cells.
    Borowski E; Bontemps-Gracz MM; Piwkowska A
    Acta Biochim Pol; 2005; 52(3):609-27. PubMed ID: 16175236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug Transporters and Multiple Drug Resistance in Pediatric Solid Tumors.
    Fruci D; Cho WC; Nobili V; Locatelli F; Alisi A
    Curr Drug Metab; 2016; 17(4):308-16. PubMed ID: 26694726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigational ABC transporter inhibitors.
    Falasca M; Linton KJ
    Expert Opin Investig Drugs; 2012 May; 21(5):657-66. PubMed ID: 22493979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.